World Café Report From the GRAPPA 2024 Annual Meeting and Trainee Symposium: Exploring GRAPPA's Future Priorities

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) annual meeting, held in Seattle, Washington, USA, in July 2024, included a World Café session in which attendees addressed the following question, "In the forthcoming five to ten years, what specific areas of unmet need should GRAPPA prioritize and how should we do so?" The World Café session was attended by rheumatologists, dermatologists, patient research partners, corporate partners, nonclinician scientists, advanced practice practitioners, and trainees. Following an introduction to the World Café process, the session took place in 10 rooms, with each room accommodating approximately 20 participants with an assigned room leader, a moderator, and a young GRAPPA member (members of whom are young clinicians and early career researchers from across the globe interested in the field of psoriatic disease [PsD]) scribe. The World Café session discussion highlighted that in the next 5 to 10 years, the most reported unmet need is research, followed by clinical, educational, and administrative priorities. Many groups identified similar specific unmet needs, including research to discover novel biomarkers; further research to address (and possibly predict) transition from psoriasis to psoriatic arthritis; multispecialty collaboration in clinical practice for the management of comorbidities; cross-specialty education for a greater understanding of PsD and its comorbidities; and the expansion of the reach and impact of GRAPPA's educational materials, recommendations, and advocacy. Ideas generated by World Café participants will inform prioritization, planning, and implementation of the 5- to 10-year organizational vision of GRAPPA.